AORT insider exercise and sale under 10b5-1 plan: 7,992 shares

Rhea-AI Filing Summary

Amy Horton, Vice President and Chief Accounting Officer of Artivion, reported exercising 7,992 stock options and selling the same 7,992 shares on 08/08/2025. The options had an exercise price of $29.62 and the shares were sold at $38.49, producing an approximate per-share gain of $8.87. After these transactions she directly owns 146,651 shares.

The sale was effected pursuant to a 10b5-1 trading plan adopted March 13, 2025. The exercised options vest at 33 1/3% per year beginning on the first anniversary of the grant; the first exercisable date was March 5, 2020 and the options expire March 5, 2026.

Positive

• Sale executed under a 10b5-1 trading plan (adopted March 13, 2025), indicating prearranged trades rather than opportunistic timing
• Realized per-share gain of $8.87 on 7,992 shares, capturing intrinsic value from vested options

Negative

• Insider sold 7,992 shares, reducing direct beneficial ownership from 154,643 to 146,651 shares
• Direct ownership declined by 7,992 shares, a reduction of approximately 5.17% of the pre-transaction holding

Insights

Securities Analyst

TL;DR Routine option exercise followed by an immediate sale under a 10b5-1 plan; net insider ownership reduced but proceeds captured.

The filing shows a standard exercise of 7,992 options at $29.62 per share and an immediate sale of those shares at $38.49. The per-share spread is $8.87, implying gross sale proceeds of approximately $307,612 and an intrinsic gain near $70,889. Transactions were executed under a documented 10b5-1 plan, which reduces timing-related signaling. Impact to outstanding insider holdings is measurable but not material to company capitalization.

Corporate Governance Expert

TL;DR Insider action aligns with prearranged trading program; disclosure is complete with option vesting and expiration details.

The report discloses both the derivative exercise and the resulting equity sale and cites the 10b5-1 plan adoption date of March 13, 2025. The option vesting schedule (33 1/3% per year) and expiration (March 5, 2026) are provided, supporting transparency. From a governance perspective, use of a 10b5-1 plan and explicit vesting/expiration disclosures are best-practice items that support compliance and reduce appearance concerns around insider timing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Horton Amy

(Last) (First) (Middle)

ARTIVION, INC.

1655 ROBERTS BLVD, NW

(Street)

KENNESAW GA 30144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/08/2025	08/08/2025	M		7,992(1)	A	$29.62	154,643	D
Common Stock	08/08/2025	08/08/2025	S		7,992(1)	D	$38.49	146,651	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$29.62	08/08/2025	08/08/2025	M			7,992	03/05/2020(2)	03/05/2026	Commn Stock	7,992	$0	0	D

Explanation of Responses:

1. The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 13, 2025.

2. Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020.

Remarks:

	/s/ Amy Horton	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Amy Horton report on Form 4 for AORT?

She exercised 7,992 stock options at an exercise price of $29.62 and sold 7,992 shares at $38.49 on 08/08/2025.

Was the sale by the Artivion officer executed under a 10b5-1 plan?

Yes. The sale was effected pursuant to a 10b5-1 trading plan adopted March 13, 2025.

How many Artivion (AORT) shares does Amy Horton own after the transactions?

146,651 shares of common stock are shown as directly beneficially owned following the reported transactions.

What are the option terms disclosed in the Form 4 for AORT?

The exercised option had an exercise price of $29.62, vests 33 1/3% per year beginning one year after grant, was first exercisable March 5, 2020, and expires March 5, 2026.

What was the per-share gain and approximate proceeds from the sale?

The per-share difference between sale and exercise was $8.87. Gross sale proceeds were about $307,612 and the intrinsic gain approximated $70,889 (before taxes and fees).